
A cell bank is a stock of identical, tested cells frozen in many small vials, so that every production batch can start from the same source. The master cell bank is the original stock, and the working cell bank is made from it and is the one drawn on for production.
Two banks, one cell line
The master cell bank (MCB) is a single pool of cells, usually prepared from the selected clone under defined conditions, split into many containers and stored under defined conditions. All working cell banks (WCB) are derived from it. The WCB is the immediate source of cells for production. According to the review, the master bank ensures that the same cell line is used consistently throughout the life cycle of a product.
How a bank is made and tested
A 2020 paper from a Barcelona academic facility shows the steps for HEK293T cells (a human cell line used to make lentiviral vectors). Cells were grown in flasks to more than 200 million cells for the MCB and 1,000 million for the WCB. They were then suspended in freezing medium made of 95% culture medium and 5% DMSO, the freezing additive in this protocol (cryopreservation means freezing cells for storage). Each cryotube (a small freezing vial) held 1 ml, at 10 million cells per ml for the MCB and 20 million per ml for the WCB.
A controlled-rate freezer lowered the temperature by 1 °C per minute. The tubes then went into a gas-phase nitrogen tank at -180 °C ± 20 °C. The MCB came to at least 60 tubes in three batches, and the WCB to at least 150 tubes in three batches.
The banks were tested for sterility, mycoplasma, karyotype (the chromosome map, which confirms the cell origin) and adventitious viruses (unwanted viruses). For the virus test, fluid from broken-up bank cells was added to three other cell cultures, which were checked for damage 14 days later. All batches met their acceptance criteria, and viability and cell concentration held for 37 months after freezing.
What the papers say is expected
The review states that banked cells from mammalian lines used to make biotech products are characterized by cell identity, freedom from cellular or microbial contaminants, presence of endogenous viral contaminants, genetic stability of the gene encoding the product, and stability over time. For cell and gene therapy products, the Barcelona paper states that cell bank generation must comply with current Good Manufacturing Practice (GMP). The review adds that records matter too: passage history, storage tank and canister number, and a label code for each tube.
Sources
- Soleimani and Ghorani, Cell bank system, establishment, and application in the virus research, diagnosis, and biopharmaceutical industries, 2025.
- Perpiñá et al., Cell Banking of HEK293T cell line for clinical-grade lentiviral particles manufacturing, Translational Medicine Communications, 19 Nov 2020.


